Raymond James Financial
NMTC icon

Raymond James Financial’s NeuroOne Medical Technologies NMTC Stock Holding History

Raymond James Financial’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,475
Closed -$10.1K – 6113
2025
Q2 		$10.1K Buy
+2,475
New +$9.14K ﹤0.01% 5922

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Raymond James Financial's NMTC Position: Q3 2025 in Review

Raymond James Financial sold out of NeuroOne Medical Technologies (NMTC) in Q3 2025, closing a stake of 2,475 shares — an estimated $10.1K sold.

Raymond James Financial first reported a position in NMTC in Q2 2025 and held it in 1 quarter. The position peaked at $10.1K in Q2 2025. 34 funds tracked by Wall St. Rank hold NMTC as of Q3 2025.

  • Raymond James Financial reported no remaining NeuroOne Medical Technologies position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 2,475 NeuroOne Medical Technologies shares in Q3 2025, an estimated $10.1K.
  • Raymond James Financial first reported a position in NeuroOne Medical Technologies in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's NeuroOne Medical Technologies position peaked at $10.1K in Q2 2025.
  • 34 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.